Stock A294090 EOFLOW CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

EOFLOW Co.,Ltd. Share Price

Equities

A294090

KR7294090006

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 31/05/2024 am IST 		5-day change 1st Jan Change
12,380 KRW -0.16% Intraday chart for EOFLOW Co.,Ltd. +3.17% +196.53%
08/02 EOFLOW Co.,Ltd. announced that it has received KRW 17 billion in funding from DB Financial Investment Co., Ltd., Samsung Securities Co., Ltd., NH Investment & Securities Co., Ltd., Tiger Investment Advisory Co.,Ltd., Hana Investment Banking & Securities Inc., Investment Arm CI
2023 EOFLOW Co.,Ltd. cancelled the transaction announced on May 25, 2023 CI

Financials

Sales 2022 6.71B 4.88M 405M Sales 2023 6.59B 4.79M 398M Capitalization 127B 92.32M 7.67B
Net income 2022 -30.71B -22.33M -1.86B Net income 2023 -61.94B -45.03M -3.74B EV / Sales 2022 62.1 x
Net cash position 2022 38.12B 27.71M 2.3B Net cash position 2023 2.15B 1.56M 130M EV / Sales 2023 18.9 x
P/E ratio 2022
-14.6 x
P/E ratio 2023
-2.05 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 89.07%
More Fundamentals * Assessed data

Chart EOFLOW Co.,Ltd.

Dynamic Chart

Latest news about EOFLOW Co.,Ltd.

EOFLOW Co.,Ltd. announced that it has received KRW 17 billion in funding from DB Financial Investment Co., Ltd., Samsung Securities Co., Ltd., NH Investment & Securities Co., Ltd., Tiger Investment Advisory Co.,Ltd., Hana Investment Banking & Securities Inc., Investment Arm CI
EOFLOW Co.,Ltd. cancelled the transaction announced on May 25, 2023 CI
Medtronic Korea Holdings Co., Ltd. cancelled the acquisition of 18.54% stake in EOFLOW Co.,Ltd. from Jaejin Kim. CI
US-based Medtronic Acquires EOFlow MT
Eoflow to Raise 314.9 Billion Won via Shares Issuance MT
Medtronic Korea Holdings Co., Ltd. agreed to acquire a 18.54% stake in EOFLOW Co.,Ltd. from Jaejin Kim for approximately KRW 170 billion. CI
EOFLOW Co.,Ltd. announced that it expects to receive KRW 314.903773785 billion in funding from Medtronic Korea Holdings Co., Ltd. CI
Pharmeo Inc. announced that it has received KRW 12.9999435 billion in funding from EOFLOW Co.,Ltd. CI
Pharmeo Inc. announced that it expects to receive KRW 12.9999435 billion in funding from EOFLOW Co.,Ltd. CI
EOFLOW Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
EOFLOW Co.,Ltd. announced that it has received KRW 32 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Securities Co., Ltd, investment arm, Kiwoom Securities Co., Ltd., Investment Arm, SUSUNG ASSET MANAGEMENT Co., Ltd. CI
EOFLOW Co.,Ltd. announced that it expects to receive KRW 32 billion in funding from Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Securities Co., Ltd, investment arm, Kiwoom Securities Co., Ltd., Investment Arm, SUSUNG ASSET MANAGEMENT Co., Ltd. CI
Pharmeo Inc. announced that it has received KRW 9.9078 billion in funding from EOFLOW Co.,Ltd. CI
Pharmeo Inc. announced that it expects to receive KRW 9.9078 billion in funding from EOFLOW Co.,Ltd. CI
Diabeloop and EOFLOW Co.,Ltd. Partners to Offer Wearable Aid with Smartphone App CI
More news

Press releases EOFLOW Co.,Ltd.

Preliminarily Enjoin Alleged Trade Secret Misappropriation Without Addressing A Time Bar Defense Under The DTSA? AQ
More press releases

Quotes and Performance

1 day-0.16%
1 week+3.17%
1 month+206.06%
3 months+140.39%
6 months+30.18%
Current year+196.53%
More quotes

Highs and lows

1 week
11 270.00
Extreme 11270
13 100.00
1 month
4 335.00
Extreme 4335
18 500.00
Current year
3 335.00
Extreme 3335
18 500.00
1 year
3 335.00
Extreme 3335
28 650.00
3 years
3 335.00
Extreme 3335
32 900.00
5 years
3 335.00
Extreme 3335
42 150.00
10 years
3 335.00
Extreme 3335
42 150.00
More quotes

Managers and Directors - EOFLOW Co.,Ltd.

Managers TitleAgeSince
Jesse Kim FOU
 Founder 62 -
Luis Malavé PSD
 President 61 17/17/17
Ian G. Welsford CTO
 Chief Tech/Sci/R&D Officer 62 01/18/01
Members of the board TitleAgeSince
Jesse Kim FOU
 Founder 62 -
Dong-Il Jo BRD
 Director/Board Member 66 -
Kyung-Jun Lee BRD
 Director/Board Member 61 -
More insiders

ETFs positioned on EOFLOW Co.,Ltd.

Name Weight AuM 1st Jan change Investor Rating
SIMPLIFY EMERGING MARKETS PLUS DOWNSIDE CONVEXITY ETF - USD ETF Simplify Emerging Markets Plus Downside Convexity ETF - USD
0.01% 4 M€ -4.41% -
More ETFs positioned on EOFLOW Co.,Ltd.

Quotes

Date Price Change Volume
31/24/31 12,380 -0.16% 1,415,321
30/24/30 12,400 +2.90% 3,902,183
29/24/29 12,050 -2.03% 2,728,143
28/24/28 12,300 -3.23% 3,837,393
27/24/27 12,710 +5.92% 7,026,673

End-of-day quote Korea S.E., May 31, 2024

More quotes

Company Profile

EOFlow Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of medical devices. The Company's main products include wearable insulin pumps, insulin infusion regulators for blood sugar control in diabetic patients.
Sector
Medical Equipment, Supplies & Distribution
Calendar
13/08/2024 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Sector Medical Equipment

1st Jan change Capi.
EOFLOW CO.,LTD. Stock EOFLOW Co.,Ltd.
+196.53% 272M
SHOCKWAVE MEDICAL, INC. Stock Shockwave Medical, Inc.
+75.69% 12.57B
PENUMBRA, INC. Stock Penumbra, Inc.
-24.68% 7.34B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+12.58% 5.39B
GETINGE AB Stock Getinge AB
-16.63% 4.84B
APT MEDICAL INC. Stock APT Medical Inc.
+26.90% 4.53B
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-22.05% 3.91B
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-22.99% 2.91B
NOVOCURE LIMITED Stock NovoCure Limited
+47.42% 2.37B
SKAN GROUP AG Stock SKAN Group AG
-0.37% 2B
Medical Equipment
  1. Stock Market
  2. Equities
  3. A294090 Stock